EQL — EQL Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeSmall CapNeutral

Annual balance sheet for EQL Pharma AB, fiscal year end - March 31st, SEK millions except per share, conversion factor applied.

	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	—	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	41.2	44.4	20.5	82.4	86.8
Net Total Accounts Receivable
Net Total Receivables	37.6	51.7	63.5	131	110
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	123	167	198	400	404
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.19	3.15	2.67	6.32	5.9
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	238	286	374	809	851
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	98.8	117	162	221	210
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	114	131	196	588	584
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	124	155	178	221	267
Total Liabilities & Shareholders' Equity	238	286	374	809	851
Total Common Shares Outstanding